Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 May 13;42(1):316.
doi: 10.1007/s00345-024-05025-x.

Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial

Affiliations
Comment

Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial

Rong Dai et al. World J Urol. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Wada N, Mizunaga M, Abe N et al (2024) Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial. World J Urol 42:113. https://doi.org/10.1007/s00345-024-04799-4 - DOI - PubMed
    1. Farag F, Sakalis VI, Arteaga SM et al (2023) What are the short-term benefits and potential harms of therapeutic modalities for the management of overactive bladder syndrome in women? A review of evidence under the auspices of the european association of urology, female non-neurogenic lower urinary tract symptoms guidelines panel. Eur Urol 84:302–312. https://doi.org/10.1016/j.eururo.2023.05.014 - DOI - PubMed
    1. Tarcan T, Selai C, Herve F et al (2020) Should we routinely assess psychological morbidities in idiopathic lower urinary tract dysfunction: ICI-RS 2019? Neurourol Urodyn 39:S70–S79. https://doi.org/10.1002/nau.24361 - DOI - PubMed
    1. Kinjo M, Masuda K, Nakamura Y et al (2023) Comparison of mirabegron and vibegron in women with treatment-naive overactive bladder: a randomized controlled study. Urology 175:67–73. https://doi.org/10.1016/j.urology.2023.02.003 - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources